Search Results - "Panahandeh, Mary C"
-
1
Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3
Published in Carcinogenesis (New York) (01-11-2009)“…Treatment of human head and neck squamous cell carcinoma (HNSCC) cell lines with guggulsterone, a widely available, well-tolerated nutraceutical, demonstrated…”
Get full text
Journal Article -
2
Targeting TORC1/2 Enhances Sensitivity to EGFR Inhibitors in Head and Neck Cancer Preclinical Models
Published in Neoplasia (New York, N.Y.) (01-11-2012)“…Abstract Head and neck squamous cell carcinoma (HNSCC) is characterized by overexpression of the epidermal growth factor receptor (EGFR) where treatments…”
Get full text
Journal Article -
3
Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma
Published in Cancer prevention research (Philadelphia, Pa.) (01-02-2011)“…Chemoprevention of head and neck squamous cell carcinoma (HNSCC), a disease associated with high mortality rates and frequent occurrence of second primary…”
Get full text
Journal Article -
4
Targeting TORC1/2 Enhances Sensitivity to EGFR Inhibitors in Head and Neck Cancer Preclinical Models1
Published in Neoplasia (New York, N.Y.) (01-11-2012)“…Head and neck squamous cell carcinoma (HNSCC) is characterized by overexpression of the epidermal growth factor receptor (EGFR) where treatments targeting EGFR…”
Get full text
Journal Article